Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-α

被引:46
作者
Hayley, S
Staines, W
Merali, Z
Anisman, H
机构
[1] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada
[2] Dept Cellular & Mol Med, Ottawa, ON, Canada
[3] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada
基金
英国医学研究理事会; 加拿大健康研究院;
关键词
tumor necrosis factor-alpha; sensitization; corticotropin-releasing hormone; vasopressin; median eminence; amygdala;
D O I
10.1016/S0306-4522(01)00276-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Stressor or cytokine treatments, such as interleukin-1 beta, promote time-dependent alterations of hypothalamic-pituitary-adrenal functioning, including increased arginine vasopressin stores within corticotropin-releasing hormone (CRH) terminals in the external zone of the median eminence. Likewise, we have previously shown that the proinflammatory cytokine, tumor necrosis factor-alpha (TNF-alpha), provoked a time-dependent sensitization of neuroendocrine and brain monoamine activity. To further explore the protracted consequences of TNF-alpha, the present investigation determined whether the cytokine sensitized activity of neuroendocrine regulatory brain regions, as assessed by c-fos expression, and had protracted consequences on amygdaloid CRH, as well as hypothalamic corticotropin secretagogues. Indeed, immunoreactivity for arginine vasopressin and corticotropin-releasing hormone, and their colocalization within cell terminals of the median eminence, varied over time following an initial 4.0-mug tumor necrosis factor-a treatment, peaking after 7 days and normalizing within 28 days. Within the central amygdala, a sensitization effect was evident as reflected by increased CRH immunoreactivity, but this effect required re-exposure to the cytokine, unlike the median eminence, changes that simply evolved with the passage of time. As well, tumor necrosis factor-a provoked a marked sensitization of c-fos staining within the paraventricular nucleus of the hypothalamus, supraoptic nucleus and the central amygdala. From these data we suggest that tumor necrosis factor-alpha influences responsivity of stressor-reactive brain regions and has protracted effects on central neuropeptide expression within the hypothalamus and central amygdala, although the time course for the effects vary across brain regions. Evidently, exposure to tumor necrosis factor-a may promote neuroplasticity of brain circuits involved in mediating neuroendocrine, sickness or inflammatory responses. It is suggested that such a sensitization may influence the response to immunological and traumatic insults and may thus be relevant to behavioral pathology. (C) 2001 IBRO. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:137 / 148
页数:12
相关论文
共 73 条
[31]   Regulation of corticotropin-releasing factor (CRF) messenger ribonucleic acid and CRF peptide in the amygdala: Studies in primary amygdalar cultures [J].
Kasckow, JW ;
Regmi, A ;
Gill, PS ;
Parkes, DG ;
Geracioti, TD .
ENDOCRINOLOGY, 1997, 138 (11) :4774-4782
[32]   SICKNESS BEHAVIOR AS A NEW TARGET FOR DRUG DEVELOPMENT [J].
KENT, S ;
BLUTHE, RM ;
KELLEY, KW ;
DANTZER, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (01) :24-28
[33]   THE TOXIC EFFECTS OF TUMOR-NECROSIS-FACTOR INVIVO AND THEIR PREVENTION BY CYCLOOXYGENASE INHIBITORS [J].
KETTELHUT, IC ;
FIERS, W ;
GOLDBERG, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (12) :4273-4277
[34]   IDENTIFICATION AND CHARACTERIZATION OF RECEPTORS FOR TUMOR-NECROSIS-FACTOR-ALPHA IN THE BRAIN [J].
KINOUCHI, K ;
BROWN, G ;
PASTERNAK, G ;
DONNER, DB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (03) :1532-1538
[35]   Tumor necrosis factor receptors in the pituitary cells [J].
Kobayashi, H ;
Fukata, J ;
Murakami, N ;
Usui, T ;
Ebisui, O ;
Muro, S ;
Hanaoka, I ;
Inoue, K ;
Imura, H ;
Nakao, K .
BRAIN RESEARCH, 1997, 758 (1-2) :45-50
[36]   Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS [J].
Konsman, JP ;
Tridon, V ;
Dantzer, R .
NEUROSCIENCE, 2000, 101 (04) :957-967
[37]   Corticotropin-releasing factor, norepinephrine, and stress [J].
Koob, GF .
BIOLOGICAL PSYCHIATRY, 1999, 46 (09) :1167-1180
[38]   SUBDIAPHRAGMATIC VAGOTOMY BLOCKS INDUCTION OF IL-1-BETA MESSENGER-RNA IN MICE BRAIN IN RESPONSE TO PERIPHERAL LPS [J].
LAYE, S ;
BLUTHE, RM ;
KENT, S ;
COMBE, C ;
MEDINA, C ;
PARNET, P ;
KELLEY, K ;
DANTZER, R .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1995, 268 (05) :R1327-R1331
[39]   Area postrema removal abolishes stimulatory effects of intravenous interleukin-1β on hypothalamic-pituitary-adrenal axis activity and c-fos mRNA in the hypothalamic paraventricular nucleus [J].
Lee, HY ;
Whiteside, MB ;
Herkenham, M .
BRAIN RESEARCH BULLETIN, 1998, 46 (06) :495-503
[40]   HYPOPHYSIOTROPIC ROLE AND HYPOTHALAMIC GENE-EXPRESSION OF CORTICOTROPIN-RELEASING FACTOR AND VASOPRESSIN IN RATS INJECTED WITH INTERLEUKIN-1-BETA SYSTEMICALLY OR INTO THE BRAIN VENTRICLES [J].
LEE, S ;
RIVIER, C .
JOURNAL OF NEUROENDOCRINOLOGY, 1994, 6 (02) :217-224